Pharma Deals Review, Vol 2009, No 12 (2009)

Font Size:  Small  Medium  Large

Intercell and GSK in Alliance for Novel Patch Vaccines

Taskin Ahmed

Abstract


GlaxoSmithKline (GSK) Biologicals SA and Austrian vaccine maker Intercell announced an agreement for a strategic alliance to develop and commercialise innovative needle-free patch-based vaccines.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.